JPMorgan Chase & Co’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Buy |
|
|||||
|
2025
Q1 | $639K | Buy |
|
|||||
|
2024
Q4 | $187K | Sell |
|
|||||
|
2024
Q3 | $1.15M | Buy |
|
|||||
|
2024
Q2 | $1.11M | Sell |
|
|||||
|
2024
Q1 | $2.08M | Buy |
|
|||||
|
2023
Q4 | $1.02M | Buy |
|
|||||
|
2023
Q3 | $1.53M | Buy |
|
|||||
|
2023
Q2 | $160K | Sell |
|
|||||
|
2023
Q1 | $742K | Sell |
|
|||||
|
2022
Q4 | $5.04M | Buy |
|
|||||
|
2022
Q3 | $978K | Sell |
|
|||||
|
2022
Q2 | $830K | Sell |
|
|||||
|
2022
Q1 | $5.3M | Sell |
|
|||||
|
2021
Q4 | $4.78M | Buy |
|
|||||
|
2021
Q3 | $2.71M | Sell |
|
|||||
|
2021
Q2 | $4.99M | Buy |
|
|||||
|
2021
Q1 | $3.58M | Buy |
|
|||||
|
2020
Q4 | $5.19M | Buy |
|
|||||
|
2020
Q3 | $4.65M | Buy |
|
|||||
|
2020
Q2 | $5.14M | Buy |
|
|||||
|
2020
Q1 | $4.95M | Sell |
|
|||||
|
2019
Q4 | $6.85M | Buy |
|
|||||
|
2019
Q3 | $2.06M | Buy |
|
|||||
|
2019
Q2 | $1.26M | Sell |
|
|||||
|
2019
Q1 | $1.22M | Buy |
|
|||||
|
2018
Q4 | $1.1M | Sell |
|
|||||
|
2018
Q3 | $2.08M | Buy |
|
|||||
|
2018
Q2 | $2.06M | Sell |
|
|||||
|
2018
Q1 | $3.88M | Sell |
|
|||||
|
2017
Q4 | $2.87M | Sell |
|
|||||
|
2017
Q3 | $3.34M | Buy |
|
|||||
|
2017
Q2 | $326K | Sell |
|
|||||
|
2017
Q1 | $6.66M | Buy |
|
|||||
|
2016
Q4 | $3.88M | Buy |
|
|||||
|
2016
Q3 | $3.64M | Buy |
|
|||||
|
2016
Q2 | $2.43M | Buy |
|
|||||
|
2016
Q1 | $2.5M | Buy |
|
|||||
|
2015
Q4 | $2.88M | Buy |
|
|||||
|
2015
Q3 | $846K | Sell |
|
|||||
|
2015
Q2 | $2.29M | Buy |
|
|||||
|
2015
Q1 | $1.45M | Sell |
|
|||||
|
2014
Q4 | $1.86M | Sell |
|
|||||
|
2014
Q3 | $1.91M | Buy |
|
|||||
|
2014
Q2 | $2.48M | Sell |
|
|||||
|
2014
Q1 | $2.21M | Sell |
|
|||||
|
2013
Q4 | $2.49M | Buy |
|